Award to Immport Therapeutics, Inc.
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 75D301-20-Q-72561
- Agency
-
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D30120P09676 Federal contract award
- Awardee
- Immport Therapeutics Inc.
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Irvine CA 92618 USA
Notice details come from SAM.gov. Updated .
Notice text
The Centers for Disease Control and Prevention (CDC), Office of Acquisition Services (OAS) on behalf of the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Deputy Director for Public Health Service and Implementation Science (DDPHSIS), Center for Preparedness and Response (CPR) has awarded a purchase order to Immport Therapeutics, Inc dba Antigen Discovery Inc for the procurement of encoded recombinant proteins by in vitro transcription/translation (IVTT) reactions of SARS-CoV2, SARS-CoV, MERS, and HCoVs ~350 clones and the printing of the proteins including controls onto custom nitrocellulose-coated microarray slides. This award was made in accordance with FAR Part 18.
Awarded contract 75D30120P09676 to unknown vendor for unknown amount on 2020-09-01.
Files
| File | Type | Posted |
|---|---|---|
| Class J and A Final 3.21.20.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity